received the Faculty Community Service and Praxis Diversity, Equity and Inclusion (DEI) Award from the UCLA Academic Senate.
- About FSPH
- Current Students
- Prospective Students
- Alumni Affairs
- Give to the School
|Departments||Type of Faculty|
|Health Policy and Management||Part Time|
Mark S. Litwin is chair of the Department of Urology, a practicing clinician, and professor of urology and health services at the David Geffen School of Medicine and the Fielding School of Public Health at UCLA. Dr. Litwin is a translational population scientist who teaches courses in health care delivery systems, medical outcomes research, quality of life assessment, and clinical urologic oncology. His research interests include medical outcomes assessment, quality of care, health-related quality of life, epidemiology, costs and resource utilization, patient preferences, and health care access for malignant and benign diseases in urology. He published the first validated quality-of-life instrument to track outcomes in men with prostate cancer and has been an international leader in this area. His research has been funded by the NIDDK, NCI, Department of Defense, American Cancer Society, California Department of Public Health, and other organizations. His current projects include a $96 million award to provide prostate cancer care to low-income, uninsured men in California, a $25 million project exploring the epidemiological burden of urological diseases in America, and several longitudinal studies of quality of life after treatment for prostate cancer. He regularly mentors fellows, residents, and students in urological health services research. Dr. Litwin earned his M.D. from Emory University Medical School and completed his residency at Harvard's Brigham and Women's Hospital. He earned his M.P.H. in health services from UCLA.
Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, Brook RH: Quality of life outcomes in men treated for localized prostate cancer. JAMA 1995;273:129-135.
Hu JC, Gold KF, Pashos CL, Mehta SS, Litwin MS. The Role of Surgeon Volume in Radical Prostatectomy Outcomes. J Clin Oncol 2003; 21: 401-405.
Spencer BA, Steinberg M, Malin J, Adams J, Litwin MS. Quality of care indicators for early stage prostate cancer. J Clin Oncol 2003; 21: 1928-1936.
Litwin MS, Saigal CS, Yano EM, Avila C, Geschwind SA, Hanley JM, Joyce GF, Madison R, Pace J, Polich SM, Wang M. Urologic Diseases in America: analytic methods and principal findings. J Urol 2005; 173: 933-937.
Miller DC, Spencer BA, Wei JT, Ritchey J, Stewart AK, Dunn RL, Sandler HM, Litwin MS. Treatment choice and quality of care for men with localized prostate cancer. Med Care 2007; 45: 401-409.
Litwin MS, Greenfield S, Elkin EP, Lubeck DP, Broering JM, Kaplan SH. Assessment of prognosis with the Total Illness Burden Index for Prostate Cancer (TIBI-CaP): validation of an instrument to aid clinicians in treatment choice. Cancer 2007; 109: 1777-1783.
Miller DC, Saigal CS, Banarjee M, Hanley J, Litwin MS. Diffusion of surgical innovation among patients with kidney cancer. Cancer 2008; 112: 1708-1717.
Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, Lin X, Greenfield TK, Litwin MS, Saigal CS, Mahadevan A, Klein E, Kibel A, Pisters L, Kuban D, Kaplan I, Wood D, Ciezki J, Shah N, Wei JT. Quality of life and satisfaction with outcome among prostate cancer survivors and their spouses. N Engl J Med 2008; 358: 1250-1261.
Nickel JC, Krieger J, White PC, McNaughton-Collins M, O'Leary MP, Anderson RU, Nadler R, Pontari M, Shoskes DA, Litwin MS, Zeitlin S, Alexander RB, Berger R; Liong ML, Chuai S, Landis JR, Kusek JW, Nyberg LM Schaeffer AJ. Effect of Alfuzosin on symptoms in men with chronic prostatitis / chronic pelvic pain syndrome. N Engl J Med 2008; 359: 2662-2673.
Gore JL, Kwan L, Lee SP, Reiter RE, Litwin MS. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer. J Nat Cancer Inst 2009; 101: 888-892
Bergman J, Chi AC, Litwin MS. Quality of end-of-life care in low-income, uninsured men dying of prostate cancer. Cancer. 2010; 116: 2126-2131.
Daskivich T, Sadetsky N, Kaplan SH, Greenfield S, Litwin MS. Severity of comorbidity and non-prostate cancer mortality in men with early-stage prostate cancer. Arch Int Med 2010. In press.
Bergman J, Saigal CS, Lorenz K, Hanley J, Miller DC, Gore JL, Litwin MS. Hospice use and high-intensity care in men dying of prostate cancer. Arch Int Med 2010. In press.